Inventor · disambiguated record
Dmitry Valentinovich Morozov
Also filed as: MOROZOV DMITRY VALENTINOVICH
12 granted patents·20 pending applications·10 citations·filing 2016–2023
83Inventor score
Top patents by PatentIndex Score
32 records- 0183US12227572B2Monoclonal antibodies against the beta chain region of human TRBV9JOINT STOCK COMPANY “BIOCAD”·Filed 2020·Granted Feb 18, 2025·2 cites·16 claims
- 0277US12297269B2Monoclonal antibodies that bind specifically to human TRBV9JOINT STOCK COMPANY “BIOCAD”·Filed 2019·Granted May 13, 2025·2 cites·22 claims
- 0376US11136408B2Anti-PD-1 antibodies, method for producing same and method for using sameJOINT STOCK COMPANY “BIOCAD”·Filed 2017·Granted Oct 5, 2021·3 cites·16 claims
- 0472US11840567B2Bispecific antibodies with specific binding to CD47 and PD-L1JOINT STOCK COMPANY “BIOCAD”·Filed 2018·Granted Dec 12, 2023·1 cites·13 claims
- 0570US11236167B2Monoclonal antibody to PD-L1JOINT STOCK COMPANY “BIOCAD”·Filed 2018·Granted Feb 1, 2022·2 cites·21 claims
- 0658US2025340613A1Bispecific antibody comprising a heterodimer based on mhc proteinsJOINT STOCK COMPANY «BIOCAD»·Filed 2022·Application pending·0 cites
- 0756US2025282847A1Codon-optimized nucleic acid encoding the fviii-bddBIOCAD JOINT STOCK CO·Filed 2023·Application pending·0 cites
- 0856US2025281640A1Nucleic acid having promoter activity and use thereofBIOCAD JOINT STOCK CO·Filed 2023·Application pending·0 cites
- 0954US2025333749A1Inducible promoter, vector and host cell based thereonJOINT STOCK COMPANY «BIOCAD»·Filed 2022·Application pending·0 cites
- 1053US2025304707A1Monoclonal antibody or antigen-binding fragment thereof that specifically binds to bcma, and use thereofBIOCAD JOINT STOCK CO·Filed 2023·Application pending·0 cites
- 1152US2025154526A1Method of obtaining a modified adeno-associated virus capsidBIOCAD JOINT STOCK CO·Filed 2022·Application pending·0 cites
- 1252US2024350663A1Isolated modified aav9 capsid protein vp1BIOCAD JOINT STOCK CO·Filed 2022·Application pending·0 cites
- 1352US2025127923A1Isolated modified capsid protein VP1 from adeno-associated virus serotype 5 (AAV5), capsid and vector based thereonBIOCAD JOINT STOCK CO·Filed 2022·Application pending·0 cites
- 1450US12202906B2Monoclonal antibody that specifically binds to CD20JOINT STOCK COMPANY “BIOCAD”·Filed 2019·Granted Jan 21, 2025·0 cites·14 claims
- 1549US2025346667A1Pharmaceutical composition of anti-trbv9 antibody and use thereofJOINT STOCK COMPANY «BIOCAD»·Filed 2023·Application pending·0 cites
- 1648US2024076691A1Codon-optimized nucleic acid encoding the fix proteinJOINT STOCK COMPANY «BIOCAD»·Filed 2022·Application pending·0 cites
- 1745US2024091383A1Synergistic effect of smn1 and mir-23a in treating spinal muscular atrophyJOINT STOCK COMPANY «BIOCAD»·Filed 2022·Application pending·0 cites
- 1845US2023321220A1Aav5-based vaccine against sars-cov-2BIOCAD JOINT STOCK CO·Filed 2021·Application pending·0 cites
- 1944US2024034764A1Immunocytokine for activating human il-10ra receptor and use thereofBIOCAD JOINT STOCK CO·Filed 2021·Application pending·0 cites
- 2043US12173075B2Anti-IL-5RAlpha monoclonal antibodyJOINT STOCK COMPANY “BIOCAD”·Filed 2018·Granted Dec 24, 2024·0 cites·26 claims
- 2143US12173336B2PaCas9 nucleaseJOINT STOCK COMPANY “BIOCAD”·Filed 2019·Granted Dec 24, 2024·0 cites·8 claims
- 2241US2023212609A1Codon-optimized nucleic acid encoding smn1 proteinLLC ANABION·Filed 2021·Application pending·0 cites
- 2339US12410257B2Monoclonal antibody that binds specifically to GITRJOINT STOCK COMPANY “BIOCAD”·Filed 2020·Granted Sep 9, 2025·0 cites·26 claims
- 2438US11993647B2Antibody or an antigen-binding fragment thereof capable of binding to a human receptor of interleukin-6JOINT STOCK COMPANY “BIOCAD”·Filed 2017·Granted May 28, 2024·0 cites·11 claims
- 2538US2023011234A1Immunocytokine comprising heterodymeric protein complex based on il-15/il-15raBIOCAD JOINT STOCK CO·Filed 2020·Application pending·0 cites
- 2636US2023203171A1Aqueous pharmaceutical composition of levilimabBIOCAD JOINT STOCK CO·Filed 2021·Application pending·0 cites
- 2734US2022306696A1Isolated modified vp1 capsid protein of aav5LLC ANABION·Filed 2020·Application pending·0 cites
- 2831US2025262153A1Aqueous pharmaceutical composition of anti-pd1 antibody prolgolimab and use thereofBIOCAD JOINT STOCK CO·Filed 2020·Application pending·0 cites
- 2929US11840531B2CDK8/19 inhibitorsJOINT STOCK COMPANY “BIOCAD”·Filed 2019·Granted Dec 12, 2023·0 cites·15 claims
- 3028US11453717B2Trispecific antibodies against IL-17A, IL-17F and other pro-inflammatory moleculeJOINT STOCK COMPANY “BIOCAD”·Filed 2016·Granted Sep 27, 2022·0 cites·23 claims
- 3128US2020339544A1Epidermal growth factor receptor inhibitorsBIOCAD JOINT STOCK CO·Filed 2018·Application pending·0 cites
- 3219US2022098160A1Novel cdk 8/19 inhibitorsBIOCAD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dmitry Valentinovich Morozov files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →